Conference Coverage (AASLD)
Pegylated IFN May Offer Advantage Over Standard Treatment
Published in Hepatitis Weekly, November 23rd, 1998
Pegylated 40K-interferon alpha-2a (Hoffmann-La Roche) was shown to be far more effective than regular interferon treatment in a study funded by the manufacturer presented at the 49th Annual Meeting of the American Association for the Study of Liver Diseases, held November 6-10, 1998, in Chicago, Illinois.
Data from the ongoing Phase II study, involving 155 patients, were presented by Michael Fried of the University of North Carolina at Chapel Hill.
"One of the greatest needs in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1998-11-23)
More Articles from Hepatitis Weekly
- Conference Coverage (AASLD)
Healthcare System May Be Overwhelmed by HCV Cases - Conference Coverage
HCV Infection Involved in Early HCC - Conference Coverage (AASLD)
HCV+ African-Americans Respond Poorly to IFN - Conference Coverage (AASLD)
HIV Associated with Cirrhosis in HCV Coinfected Patients - Conference Coverage (AASLD)
Study Suggests TTV Associated with Unexplained Liver Disease - Geriatrics
HCV Impact on Chronic Liver Disease in Elderly Studied - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
